Q-Line Biotech IPO GMP, Grey Market Premium Today

Check out Q-Line Biotech IPO GMP aka IPO Grey Market Premium, Kostak rates, and Subject to Sauda rates as of today. Q-Line Biotech IPO GMP is started in grey market, lets wait for the IPO announcement. Stay tuned for the latest IPO GMP numbers of Q-Line Biotech IPO.
Q-Line Biotech IPO

Q-Line Biotech IPO is to open on May 21, 2026. It is an NSE SME IPOĀ that will raise ₹214 crores. The Q-Line Biotech IPOĀ price band is fixed at ₹326 to ₹343 with a market lot of 11 Shares.

Q-Line Biotech IPO GMP Live Rates day by day with Kostak rates.

DateIPO GMPGMP TrendGain
18 May₹6518.95%

Q-Line Biotech IPO Details

IPO Open DateMay 21, 2025
IPO Close DateMay 25, 2025
Face Value₹10 Per Equity Share
IPO Price Band₹326 to ₹343 Per Share
Issue SizeApprox ₹214 Crores
Fresh IssueApprox ₹214 Crores
Issue TypeBook Built Issue
IPO ListingNSE SME
DRHP Draft ProspectusPDF
RHP Draft ProspectusPDF

Q-Line Biotech IPO Dates

IPO Open Date:May 21, 2026
IPO Close Date:May 25, 2026
Basis of Allotment:May 26, 2026
Refunds:May 27, 2026
Credit to Demat Account:May 27, 2026
IPO Listing Date:May 29, 2026
IPO Bidding Cut-off Time:May 25, 2026 – 5 PM

Business Overview

Since its incorporation in 2013, Q-Line Biotech has been involved in the healthcare and diagnostic industry. The firm is known for manufacturing and supplying In-Vitro Diagnostic (IVD) products, medical diagnostic equipment, reagents, rapid test kits, and pathology instruments. The firm has been known to offer high-quality products and services at an affordable price range. 

Q-Line Biotech has over 15 years of experience in the diagnostic industry and has served 150+ national and international clients. Moreover, the company also has 12 years of experience in developing and manufacturing various products. Its product range includes haematology, POC testing, clinical chemistry, molecular diagnostics, rapid tests, ELISA, and special diagnostics.


Q-Line Biotech IPO GMP aka Grey Market Premium FAQs:


What is Q-Line Biotech IPO GMP Today?

Q-Line Biotech IPO GMP is ₹65 as of today.

What is Q-Line Biotech IPO Expected Returns?

Q-Line Biotech IPO Expected Returns is 18.95%.

Disclaimer:

  • IPO Grey Market Premium (Q-Line Biotech IPO GMP) mention is valid for the specific date as mentioned in the header.
  • We are not buying and selling IPO forms on IPO Grey Market.
  • Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
  • Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.

Table of Contents

Picture of Jagat Joshi

Jagat Joshi

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.
Picture of Jagat Joshi

Jagat Joshi

Leave a Reply

Your email address will not be published. Required fields are marked *